Skip to main content

Table 6 Multivariate analysis of the predictors for the 30-day mortality

From: Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Variables Adjusted OR (95% CI) p
CURB65 score 3.18 (1.44–6.99) 0.004
Mechanical ventilation 6.38 (1.16–35.23) 0.034
Bacteremia 21.00 (0.99–443.40) 0.050
Duration of Tigecycline treatment 0.97 (0.87–1.08) 0.567
Tigecycline resistance 0.20 (0.05–0.78) 0.021
  1. Abbreviations: OR odd ratio, CI confidence interval, MDRAB multidrugresistant Acinetobacter baumannii